How Gilead Sciences (GILD) Makes Money: A Visual Guide
Gilead Sciences (GILD) generated $29.44B in revenue (TTM through Q4 2025), earning $8.51B in net profit (28.9% margin). Its largest revenue source is Products, Other HIV (75.2% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.
Gilead Sciences (GILD) Income Statement Flow
Frequently asked questions
How does Gilead Sciences (GILD) make money?
- Gilead Sciences (GILD) primarily makes money through Products, Other HIV, which accounts for 75.2% of total revenue. For TTM through Q4 2025, Gilead Sciences generated $29.44B in total revenue with a net profit margin of 28.9%.
What is Gilead Sciences (GILD) gross profit margin?
- Gilead Sciences (GILD) reported a gross profit margin of 80.8% for TTM through Q4 2025, equivalent to $23.79B in gross profit. This means Gilead Sciences retains 80.8% of each revenue unit after direct costs of production.
What is Gilead Sciences (GILD) operating profit margin?
- Gilead Sciences (GILD) reported an operating profit margin of 37.4% for TTM through Q4 2025, equivalent to $11.00B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Gilead Sciences (GILD) net profit margin?
- Gilead Sciences (GILD) reported a net profit margin of 28.9% for TTM through Q4 2025, equivalent to $8.51B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Gilead Sciences (GILD) invest in R&D?
- Gilead Sciences (GILD) invested $5.78B in research and development in TTM through Q4 2025 (19.6% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Gilead Sciences (GILD) spend on capital expenditures?
- Gilead Sciences (GILD) spent $563.00M on capital expenditures in TTM through Q4 2025 (1.9% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Gilead Sciences (GILD) free cash flow?
- Gilead Sciences (GILD) generated $9.46B in free cash flow for TTM through Q4 2025 (32.1% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is Gilead Sciences (GILD) effective tax rate?
- Gilead Sciences (GILD) had an effective tax rate of 13.1% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.
About this data
- What is a Sankey diagram?
- A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
- How is the data calculated?
- We use the income statement from company filings. For TTM (Trailing Twelve Months), we sum the last four quarters. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
- When was this data last updated?
- Based on company filings through TTM through Q4 2025.